
Corner Therapeutics
Provider of biotechnology research services intended to stimulate exceptional memory T cells for lifelong immunity. The company's technologies offer a versatile dendritic cell hyperactivation (hDC) pl...
Valuation
$0
Share Price
N/A
Total Raised
$75.3M
Last Round
N/A